Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Selin Kestel"'
Publikováno v:
Türk Patoloji Dergisi, Vol 39, Iss 3, Pp 169-178 (2023)
Objective: In a study of Merkel cell carcinoma (MCC), a fusion transcript between MLH1 and SPATA4 was identified. This fusion has the potential to generate the inactive or dominant-negative form of the protein. Therefore, we aimed to investigate whet
Externí odkaz:
https://doaj.org/article/50b1e792ccd14a79a0bbfa8cdda53af4
Publikováno v:
Journal of Pathology and Translational Medicine, Vol 56, Iss 4, Pp 187-198 (2022)
Background We aimed to determine the effect of clinicopathologic features on overall survival among Caucasian ocular melanoma patients in the Central Anatolia region of Turkey. Methods This single-center study included conjunctival (n = 12) and uveal
Externí odkaz:
https://doaj.org/article/3b8287f62f4e4c5d84a466cf599e4b30
Publikováno v:
Türk Patoloji Dergisi, Vol 36, Iss 3, Pp 246-250 (2020)
Pneumocystis jirovecii is a potentially life-threatening opportunistic pathogen particularly affecting the lungs, mainly in immunosuppressed individuals and HIV-infected patients with a low CD4 cell count. A 50-year-old man presented with a 1-week hi
Externí odkaz:
https://doaj.org/article/b94af8145a074bb8b2216788575f42ee
Five-year survival for melanoma with distant metastasis has been reported as 25%. This study evaluates the relationship between known and uncertain clinicopathologic parameters and overall survival (OS) for metastatic melanoma patients.Metastatic mel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::242940cd79a005542a08b2a8e6a3d145
https://avesis.gazi.edu.tr/publication/details/e90e2732-660a-45df-be6e-14eafd2c946a/oai
https://avesis.gazi.edu.tr/publication/details/e90e2732-660a-45df-be6e-14eafd2c946a/oai
Publikováno v:
Türk Patoloji Dergisi, Vol 36, Iss 3, Pp 246-250 (2020)
Pneumocystis jirovecii is a potentially life-threatening opportunistic pathogen particularly affecting the lungs, mainly in immunosuppressed individuals and HIV-infected patients with a low CD4 cell count. A 50-year-old man presented with a 1-week hi